Bank of Nova Scotia
FLGT icon

Bank of Nova Scotia’s Fulgent Genetics FLGT Stock Holding History

Bank of Nova Scotia’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,414
Closed -$3.08M – 1234
2021
Q3 		$3.08M Sell
34,414
-17,272
-33% -$1.57M 0.01% 761
2021
Q2 		$4.76M Buy
51,686
+47,924
+1,274% +$3.83M 0.01% 603
2021
Q1 		$364K Buy
+3,762
New +$388K ﹤0.01% 994

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of Nova Scotia's FLGT Position: Q4 2021 in Review

Bank of Nova Scotia sold out of Fulgent Genetics (FLGT) in Q4 2021, closing a stake of 34,414 shares — an estimated $3.08M sold.

Bank of Nova Scotia first reported a position in FLGT in Q1 2021 and held it in 3 quarters. The position peaked at $4.76M in Q2 2021. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

  • Bank of Nova Scotia reported no remaining Fulgent Genetics position as of Q4 2021 after selling out during the quarter.
  • Bank of Nova Scotia sold 34,414 Fulgent Genetics shares in Q4 2021, an estimated $3.08M.
  • Bank of Nova Scotia first reported a position in Fulgent Genetics in Q1 2021 and held it in 3 quarters.
  • Bank of Nova Scotia's Fulgent Genetics position peaked at $4.76M in Q2 2021.
  • 299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on Bank of Nova Scotia's 13F filing for Q4 2021, filed 11 Feb 2022.